Para-menthane-3, 8-diol (PMD)
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Paediatric Vaccine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Pneumococcal 1.2.3 Varicella 1.2.4 Combinations 1.2.5 Poliovirus 1.2.6 Hepatitis 1.2.7 MMR 1.2.8 Pediatric Hormones 1.2.9 HIB 1.2.10 Allergy and Respiratory vaccines 1.2.11 Other Pediatric vaccines 1.3 Market by Application 1.3.1 Global Paediatric Vaccine Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Age (0-3) 1.3.3 Age (3-12) 1.3.4 Age Above 12 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Paediatric Vaccine Market Perspective (2017-2028) 2.2 Paediatric Vaccine Growth Trends by Region 2.2.1 Paediatric Vaccine Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Paediatric Vaccine Historic Market Size by Region (2017-2022) 2.2.3 Paediatric Vaccine Forecasted Market Size by Region (2023-2028) 2.3 Paediatric Vaccine Market Dynamics 2.3.1 Paediatric Vaccine Industry Trends 2.3.2 Paediatric Vaccine Market Drivers 2.3.3 Paediatric Vaccine Market Challenges 2.3.4 Paediatric Vaccine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Paediatric Vaccine Players by Revenue 3.1.1 Global Top Paediatric Vaccine Players by Revenue (2017-2022) 3.1.2 Global Paediatric Vaccine Revenue Market Share by Players (2017-2022) 3.2 Global Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Paediatric Vaccine Revenue 3.4 Global Paediatric Vaccine Market Concentration Ratio 3.4.1 Global Paediatric Vaccine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Paediatric Vaccine Revenue in 2021 3.5 Paediatric Vaccine Key Players Head office and Area Served 3.6 Key Players Paediatric Vaccine Product Solution and Service 3.7 Date of Enter into Paediatric Vaccine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Paediatric Vaccine Breakdown Data by Type 4.1 Global Paediatric Vaccine Historic Market Size by Type (2017-2022) 4.2 Global Paediatric Vaccine Forecasted Market Size by Type (2023-2028) 5 Paediatric Vaccine Breakdown Data by Application 5.1 Global Paediatric Vaccine Historic Market Size by Application (2017-2022) 5.2 Global Paediatric Vaccine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Paediatric Vaccine Market Size (2017-2028) 6.2 North America Paediatric Vaccine Market Size by Country (2017-2022) 6.3 North America Paediatric Vaccine Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Paediatric Vaccine Market Size (2017-2028) 7.2 Europe Paediatric Vaccine Market Size by Country (2017-2022) 7.3 Europe Paediatric Vaccine Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Paediatric Vaccine Market Size (2017-2028) 8.2 Asia-Pacific Paediatric Vaccine Market Size by Country (2017-2022) 8.3 Asia-Pacific Paediatric Vaccine Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Paediatric Vaccine Market Size (2017-2028) 9.2 Latin America Paediatric Vaccine Market Size by Country (2017-2022) 9.3 Latin America Paediatric Vaccine Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Paediatric Vaccine Market Size (2017-2028) 10.2 Middle East & Africa Paediatric Vaccine Market Size by Country (2017-2022) 10.3 Middle East & Africa Paediatric Vaccine Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 GlaxoSmithCline 11.1.1 GlaxoSmithCline Company Detail 11.1.2 GlaxoSmithCline Business Overview 11.1.3 GlaxoSmithCline Paediatric Vaccine Introduction 11.1.4 GlaxoSmithCline Revenue in Paediatric Vaccine Business (2017-2022) 11.1.5 GlaxoSmithCline Recent Development 11.2 Merck 11.2.1 Merck Company Detail 11.2.2 Merck Business Overview 11.2.3 Merck Paediatric Vaccine Introduction 11.2.4 Merck Revenue in Paediatric Vaccine Business (2017-2022) 11.2.5 Merck Recent Development 11.3 Sanofi 11.3.1 Sanofi Company Detail 11.3.2 Sanofi Business Overview 11.3.3 Sanofi Paediatric Vaccine Introduction 11.3.4 Sanofi Revenue in Paediatric Vaccine Business (2017-2022) 11.3.5 Sanofi Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Detail 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Paediatric Vaccine Introduction 11.4.4 Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2017-2022) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Abbott Laboratories 11.5.1 Abbott Laboratories Company Detail 11.5.2 Abbott Laboratories Business Overview 11.5.3 Abbott Laboratories Paediatric Vaccine Introduction 11.5.4 Abbott Laboratories Revenue in Paediatric Vaccine Business (2017-2022) 11.5.5 Abbott Laboratories Recent Development 11.6 Eli Lilly 11.6.1 Eli Lilly Company Detail 11.6.2 Eli Lilly Business Overview 11.6.3 Eli Lilly Paediatric Vaccine Introduction 11.6.4 Eli Lilly Revenue in Paediatric Vaccine Business (2017-2022) 11.6.5 Eli Lilly Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Detail 11.7.2 Pfizer Business Overview 11.7.3 Pfizer Paediatric Vaccine Introduction 11.7.4 Pfizer Revenue in Paediatric Vaccine Business (2017-2022) 11.7.5 Pfizer Recent Development 11.8 F. Hoffmann-La Roche 11.8.1 F. Hoffmann-La Roche Company Detail 11.8.2 F. Hoffmann-La Roche Business Overview 11.8.3 F. Hoffmann-La Roche Paediatric Vaccine Introduction 11.8.4 F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2017-2022) 11.8.5 F. Hoffmann-La Roche Recent Development 11.9 Novo Nordisk 11.9.1 Novo Nordisk Company Detail 11.9.2 Novo Nordisk Business Overview 11.9.3 Novo Nordisk Paediatric Vaccine Introduction 11.9.4 Novo Nordisk Revenue in Paediatric Vaccine Business (2017-2022) 11.9.5 Novo Nordisk Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Paediatric Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Pneumococcal Table 3. Key Players of Varicella Table 4. Key Players of Combinations Table 5. Key Players of Poliovirus Table 6. Key Players of Hepatitis Table 7. Key Players of MMR Table 8. Key Players of Pediatric Hormones Table 9. Key Players of HIB Table 10. Key Players of Allergy and Respiratory vaccines Table 11. Key Players of Other Pediatric vaccines Table 12. Global Paediatric Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 13. Global Paediatric Vaccine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 14. Global Paediatric Vaccine Market Size by Region (2017-2022) & (US$ Million) Table 15. Global Paediatric Vaccine Market Share by Region (2017-2022) Table 16. Global Paediatric Vaccine Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 17. Global Paediatric Vaccine Market Share by Region (2023-2028) Table 18. Paediatric Vaccine Market Trends Table 19. Paediatric Vaccine Market Drivers Table 20. Paediatric Vaccine Market Challenges Table 21. Paediatric Vaccine Market Restraints Table 22. Global Paediatric Vaccine Revenue by Players (2017-2022) & (US$ Million) Table 23. Global Paediatric Vaccine Market Share by Players (2017-2022) Table 24. Global Top Paediatric Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Vaccine as of 2021) Table 25. Ranking of Global Top Paediatric Vaccine Companies by Revenue (US$ Million) in 2021 Table 26. Global 5 Largest Players Market Share by Paediatric Vaccine Revenue (CR5 and HHI) & (2017-2022) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Paediatric Vaccine Product Solution and Service Table 29. Date of Enter into Paediatric Vaccine Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Paediatric Vaccine Market Size by Type (2017-2022) & (US$ Million) Table 32. Global Paediatric Vaccine Revenue Market Share by Type (2017-2022) Table 33. Global Paediatric Vaccine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 34. Global Paediatric Vaccine Revenue Market Share by Type (2023-2028) Table 35. Global Paediatric Vaccine Market Size by Application (2017-2022) & (US$ Million) Table 36. Global Paediatric Vaccine Revenue Market Share by Application (2017-2022) Table 37. Global Paediatric Vaccine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 38. Global Paediatric Vaccine Revenue Market Share by Application (2023-2028) Table 39. North America Paediatric Vaccine Market Size by Country (2017-2022) & (US$ Million) Table 40. North America Paediatric Vaccine Market Size by Country (2023-2028) & (US$ Million) Table 41. Europe Paediatric Vaccine Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Paediatric Vaccine Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia-Pacific Paediatric Vaccine Market Size by Region (2017-2022) & (US$ Million) Table 44. Asia-Pacific Paediatric Vaccine Market Size by Region (2023-2028) & (US$ Million) Table 45. Latin America Paediatric Vaccine Market Size by Country (2017-2022) & (US$ Million) Table 46. Latin America Paediatric Vaccine Market Size by Country (2023-2028) & (US$ Million) Table 47. Middle East & Africa Paediatric Vaccine Market Size by Country (2017-2022) & (US$ Million) Table 48. Middle East & Africa Paediatric Vaccine Market Size by Country (2023-2028) & (US$ Million) Table 49. GlaxoSmithCline Company Detail Table 50. GlaxoSmithCline Business Overview Table 51. GlaxoSmithCline Paediatric Vaccine Product Table 52. GlaxoSmithCline Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 53. GlaxoSmithCline Recent Development Table 54. Merck Company Detail Table 55. Merck Business Overview Table 56. Merck Paediatric Vaccine Product Table 57. Merck Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 58. Merck Recent Development Table 59. Sanofi Company Detail Table 60. Sanofi Business Overview Table 61. Sanofi Paediatric Vaccine Product Table 62. Sanofi Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 63. Sanofi Recent Development Table 64. Bristol-Myers Squibb Company Detail Table 65. Bristol-Myers Squibb Business Overview Table 66. Bristol-Myers Squibb Paediatric Vaccine Product Table 67. Bristol-Myers Squibb Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 68. Bristol-Myers Squibb Recent Development Table 69. Abbott Laboratories Company Detail Table 70. Abbott Laboratories Business Overview Table 71. Abbott Laboratories Paediatric Vaccine Product Table 72. Abbott Laboratories Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 73. Abbott Laboratories Recent Development Table 74. Eli Lilly Company Detail Table 75. Eli Lilly Business Overview Table 76. Eli Lilly Paediatric Vaccine Product Table 77. Eli Lilly Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 78. Eli Lilly Recent Development Table 79. Pfizer Company Detail Table 80. Pfizer Business Overview Table 81. Pfizer Paediatric Vaccine Product Table 82. Pfizer Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 83. Pfizer Recent Development Table 84. F. Hoffmann-La Roche Company Detail Table 85. F. Hoffmann-La Roche Business Overview Table 86. F. Hoffmann-La Roche Paediatric Vaccine Product Table 87. F. Hoffmann-La Roche Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 88. F. Hoffmann-La Roche Recent Development Table 89. Novo Nordisk Company Detail Table 90. Novo Nordisk Business Overview Table 91. Novo Nordisk Paediatric Vaccine Product Table 92. Novo Nordisk Revenue in Paediatric Vaccine Business (2017-2022) & (US$ Million) Table 93. Novo Nordisk Recent Development Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Global Paediatric Vaccine Market Share by Type: 2021 VS 2028 Figure 2. Pneumococcal Features Figure 3. Varicella Features Figure 4. Combinations Features Figure 5. Poliovirus Features Figure 6. Hepatitis Features Figure 7. MMR Features Figure 8. Pediatric Hormones Features Figure 9. HIB Features Figure 10. Allergy and Respiratory vaccines Features Figure 11. Other Pediatric vaccines Features Figure 12. Global Paediatric Vaccine Market Share by Application in 2021 & 2028 Figure 13. Age (0-3) Case Studies Figure 14. Age (3-12) Case Studies Figure 15. Age Above 12 Case Studies Figure 16. Paediatric Vaccine Report Years Considered Figure 17. Global Paediatric Vaccine Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 18. Global Paediatric Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 19. Global Paediatric Vaccine Market Share by Region: 2021 VS 2028 Figure 20. Global Paediatric Vaccine Market Share by Players in 2021 Figure 21. Global Top Paediatric Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Vaccine as of 2021) Figure 22. The Top 10 and 5 Players Market Share by Paediatric Vaccine Revenue in 2021 Figure 23. North America Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. North America Paediatric Vaccine Market Share by Country (2017-2028) Figure 25. United States Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Canada Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Europe Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Europe Paediatric Vaccine Market Share by Country (2017-2028) Figure 29. Germany Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. France Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. U.K. Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Italy Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Russia Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Nordic Countries Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Asia-Pacific Paediatric Vaccine Market Share by Region (2017-2028) Figure 37. China Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Latin America Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Latin America Paediatric Vaccine Market Share by Country (2017-2028) Figure 45. Mexico Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Brazil Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Middle East & Africa Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Paediatric Vaccine Market Share by Country (2017-2028) Figure 49. Turkey Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Saudi Arabia Paediatric Vaccine Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. GlaxoSmithCline Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 52. Merck Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 53. Sanofi Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 55. Abbott Laboratories Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 56. Eli Lilly Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 57. Pfizer Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 59. Novo Nordisk Revenue Growth Rate in Paediatric Vaccine Business (2017-2022) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed
GlaxoSmithCline Merck Sanofi Bristol-Myers Squibb Abbott Laboratories Eli Lilly Pfizer F. Hoffmann-La Roche Novo Nordisk
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More